Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 542678 | NSE Symbol : | ISIN : INE05BN01019 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
03-Jul-2024	12-Jul-2024	Increase in Authorised Capital	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2024 inter alia to consider and approve Increase in Authorized Capital of company and to considered and approve the proposal of issue of equity shares on preferential basic. The Board Meeting to be held on 09/07/2024 has been revised to 12/07/2024 The Board Meeting to be held on 09/07/2024 has been revised to 12/07/2024 (As per BSE Announcement Dated on 08/07/2024) 1. Approved the proposal of issue of equity shares on preferential basic and authorize Mr. Suraj Zanwar to record the names of proposed allottees and to complete all procedural formalities required for preferential issue. 2. Approved the proposal of increase in authorized capital and authorize Mr. Suraj Zanwar- Managing Director to submit details of how much capita needs to be increase before the next board meeting (As per BSE Announcement Dated on 13/07/2024)
09-Jun-2024	14-Jun-2024	Raising funds through Debt Instr.	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To Discuss and reconsider the Investment Planning and Fund-raising Proposal etc.
01-Jun-2024	05-Jun-2024	Raising funds through Debt Instr.	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve To Discuss and Consider the Investment Planning and Fund-raising Proposal mode of funding To authorized Mr. Suraj Zanwar- Managing Director of company to prepare details plan of Investment proposal and working capital requirement of the company (As Per BSE Announcement Dated on 09.06.2024)
20-May-2024	30-May-2024	Accounts	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve To consider and approve Audited financial results for Year ended on 31st march 2024 Revised financials for financial year ending on 31st march 2024 due to mission of attachment consolidated results (As Per BSE Announcement Dated on 31.05.2024)
18-Jan-2024	17-Jan-2024	Change in Directors	Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024
30-Dec-2023	30-Dec-2023	Postal Ballot	Revised Outcome of Board meeting for migration of Company''s present listing of equity shares from SME Platform of BSE Limited to Main Board of NSE Platform. Filing revised Outcome as in earlier outcome we by mistake mentioned as NSE Emerge instead of NSE Main Board. Migration of Company''s present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of NSE Emerge Platform.
06-Nov-2023	14-Nov-2023	Half Yearly Results	Half Yearly Results Outcome of Meeting of board of Director dated 14th November, 2023 Declaration of financial results for the half year ended on 30th September, 2023 (As Per BSE Announcement Dated on 14/11/2023)
12-Oct-2023	12-Oct-2023	Change in Directors	Intimation of appointment of Additional Director (Executive category) w.e.f 11th October, 2023.
24-May-2023	30-May-2023	Accounts	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Meeting of the Board of Directors of the Company scheduled to be held on Tuesday 30th May 2023 inter-alia to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the half year and year ended March 31st 2023.
08-Nov-2022	14-Nov-2022	Half Yearly Results	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve In terms of the Regulation 29(1) (a) of the SEBI (LODR) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th November 2022 inter-alia to consider and approve the un-audited financial results (standalone and consolidated) along with Limited review report and annexure of the Company for the half year ended September 30 2022. In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 (''Listing Regulations''), please be informed that the Board of Directors at its meeting held on today i.e., Monday, November 14, 2022, to inter alia considered and approved the Un-Audited Financial Results (standalone and consolidated) for the quarter and half year ended September 30, 2022 and took on record the Limited Review Report issued by the Statutory Auditors of the Company. (As Per BSE Announcement Dated on 14/11/2022)
22-Sep-2022	26-Sep-2022	Postal Ballot	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/09/2022 inter alia to consider and approve 1. To Considered and approve the proposal of migration of Companys present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 2. To approve the draft Notice of Postal Ballot for Migration of the Companys present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 3. other transactions as specified in intimation attached This is to inform that the Board of Directors of the Company have, at their Meeting held on today i.e. Monday, September 26, 2022 inter alia, considered and approved the following key agendas: 1. Approved the proposal of migration of Company''s present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 2. Approved the draft Notice of Postal Ballot for Migration of the Company''s present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 3. The Board has fixed Friday, 23rd September, 2022 as a cut-off date for determining the eligibility of the members to receive Postal Ballot Notice and to exercise voting rights by remote evoting. other items as mentioned in intimation (As Per BSE Announcement Dated on 26.09.2022) Board approved:- 1. Approved the proposal of migration of Company's present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 2. Approved the draft Notice of Postal Ballot for Migration of the Company's present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of BSE Limited. 3. The Board has fixed Friday, 23rd September, 2022 as a cut-off date for determining the eligibility of the members to receive Postal Ballot Notice and to exercise voting rights by remote evoting. 4. Appointed CS Sanam Umbargikar, Practicing Company Secretary, from Mumbai as a Scrutinizer to conduct the postal Ballot process. 5. Authorized Mr. Suraj Zanwar - Managing Director of Company and Mr. Munjaji Dhumal- Company Secretary & Compliance Officer to sign, submit, execute etc. applications, forms, documents with BSE, ROC and other authorities. (As Per BSE Bulletin Dated on 27.09.2022)
25-May-2022	30-May-2022	Accounts	Audited Results Submission Of Audited Financials Results For The Half Year/Year Ended On 31St March, 2022 Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are pleased to submit the Audited Financials Results for the Half year/Year ended 31st March, 2022 which was also approved by the Board of Directors of the Company at their meeting held on Monday, 30th May, 2022 at 5:00 P.M. and concluded at 6:55 P.M. (As Per BSE Announcement Dated on 30/05/2022)
17-Dec-2021	22-Dec-2021	Preferential Issue	Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/12/2021 ,inter alia, to consider and approve To consider and approve the allotment of 16,35,000 equity Shares on preferential bases under Private Placement Preferential Issue of shares (Revised) A Meeting of the Board of Directors of the Company which was scheduled to be held on Tuesday, 21st December, 2021 was not held due to some technical and unavoidable reasons and which is rescheduled to be held on 22nd December, 2021 inter-alia to transact the following business: 1. To consider and approve the allotment of 16,35,000 equity Shares on preferential bases under Private Placement. (As per BSE Bulletin Dated on 21.12.2021) Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2021 ,inter alia, to consider and approve In terms of the Regulation 29 of the SEBI (LODR) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company which was scheduled to be held on Tuesday, 21st December, 2021 was not held due to some technical and unavoidable reasons and which is rescheduled to be held on 22nd December, 2021 inter-alia to transact the following business: 1. To consider and approve the allotment of 16,35,000 equity Shares on preferential bases under Private Placement. (As per BSE Announcement Dated on 21/12/2021) Further to our intimation dated December 17, 2021 and December 21, 2021 and pursuance to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 (''Listing Regulations''), please be informed that the Board of Directors of CIAN HEALTHCARE LIMITED at its meeting held today i.e., Wednesday, December 22, 2021, has inter alia considered and approved the following: -Allotment of 16,35,000 equity Shares on preferential bases under Private Placement. (As per BSE Announcement Dated on 22/12/2021)
08-Nov-2021	17-Nov-2021	Half Yearly Results	Half Yearly Results Half Yearly Results (Revised) (As per BSE Bulletin Dated on 15/11/2021) Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/11/2021 ,inter alia, to consider and approve In terms of the Regulation 29(1) (a) of the SEBI (LODR) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company which was scheduled to be held on Sunday, 14th November, 2021 was not held due to some internal technical reasons and which is rescheduled to be held on 16th November, 2021 inter-alia, to consider and approve the un-audited financial results (standalone and consolidated) along with Limited review report and annexure of the Company for the half year ended September 30, 2021. (As Per BSE Announcement Dated on 14.11.2021) In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 (''Listing Regulations''), please be informed that the board meeting which was propose to be held on 16th November, 2021 was rescheduled and held today i.e., Wednesday, November 17, 2021, to inter alia considered and approved the Un-Audited Financial Results (standalone and consolidated) for the quarter and half year ended September 30, 2021 and took on record the Limited Review Report issued by the Statutory Auditors of the Company. The Company has not filed financials Statement within timeline as prescribed under Regulation 33 of SEBI (LODR) Regulation due to the non-finalization of financials statements within time as there was an internal technical issue in account department. The aforesaid Board Meeting commenced at 05:00 PM and concluded at 07:40 PM on November 17, 2021. (As Per BSE Announcement Dated on 17.11.2021)
27-Oct-2021	29-Oct-2021	Preferential Issue	Preferential Issue of shares Raising of funds by issue of equity Shares on preferential basis under private placement through permissible modes subject to necessary shareholders/ regulatory approvals, as applicable. In compliance with the requirement under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations'), Board of directors of Company in the meeting held on today i.e. 29th October, 2021 passed a resolution for cancellation of Resolutions No. 02. TO ISSUE EQUITY SHARES ON A PREFERENTIAL BASIS UNDER PRIVATE PLACEMENT passed by the shareholders of Company in the Extra-Ordinary General Meeting which was held on 12th October, 2021. The aforesaid resolution is cancelled due to some non-disclosure to Shareholders in the Notice of EOGM which was occurred due to Scanning mistake of Notice of EOGM at the time of sending the notice to Shareholder by email. (As Per BSE Announcement dated on 29.10.2021)

1 2

LOGIN HERE

Cian Healthcare Ltd

Board Meeting